These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 2158362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC.
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [Abstract] [Full Text] [Related]

  • 5. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD, Nikiforovich GV, Golbraikh AA.
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [Abstract] [Full Text] [Related]

  • 6. A conformational comparison of two stereoisomeric cyclic dermorphin analogues employing NMR and computer simulations.
    Mierke DF, Schiller PW, Goodman M.
    Biopolymers; 1990 Apr; 29(6-7):943-52. PubMed ID: 2369622
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW, Nguyen TM, Lemieux C, Maziak LA.
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995 Dec; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
    Chao TM, Perez JJ, Loew GH.
    Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
    [Abstract] [Full Text] [Related]

  • 10. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C.
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
    Pelton JT, Kazmierski W, Gulya K, Yamamura HI, Hruby VJ.
    J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
    [Abstract] [Full Text] [Related]

  • 12. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M, Sagan S, Mor A, Delfour A, Nicolas P.
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [Abstract] [Full Text] [Related]

  • 13. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S, Sagan S, Delfour A, Nicolas P.
    Biochem Biophys Res Commun; 1991 Sep 30; 179(3):1161-8. PubMed ID: 1656944
    [Abstract] [Full Text] [Related]

  • 14. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.
    Nikiforovich GV, Hruby VJ.
    Biochem Biophys Res Commun; 1990 Dec 14; 173(2):521-7. PubMed ID: 1979733
    [Abstract] [Full Text] [Related]

  • 15. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 16. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
    Kazmierski W, Wire WS, Lui GK, Knapp RJ, Shook JE, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1988 Nov 09; 31(11):2170-7. PubMed ID: 2903246
    [Abstract] [Full Text] [Related]

  • 17. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T, Said-Nejad OE, Schiller PW, Goodman M.
    Biopolymers; 1991 Jun 09; 31(7):877-98. PubMed ID: 1655089
    [Abstract] [Full Text] [Related]

  • 18. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
    Segawa M, Ohno Y, Doi M, Ishida T, Iwashita T.
    Int J Pept Protein Res; 1995 Jul 09; 46(1):37-46. PubMed ID: 7558595
    [Abstract] [Full Text] [Related]

  • 19. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
    Segawa M, Ohno Y, Doi M, Inoue M, Ishida T, Iwashita T.
    Int J Pept Protein Res; 1994 Sep 09; 44(3):295-304. PubMed ID: 7822107
    [Abstract] [Full Text] [Related]

  • 20. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
    Sagan S, Amiche M, Delfour A, Mor A, Camus A, Nicolas P.
    J Biol Chem; 1989 Oct 15; 264(29):17100-6. PubMed ID: 2551895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.